Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Safety and efficacy of cyproheptadine for treating dyspeptic symptoms in children.

Rodriguez L, Diaz J, Nurko S.

J Pediatr. 2013 Jul;163(1):261-7. doi: 10.1016/j.jpeds.2012.12.096. Epub 2013 Feb 16.

2.

Cyproheptadine Use in Children With Functional Gastrointestinal Disorders.

Madani S, Cortes O, Thomas R.

J Pediatr Gastroenterol Nutr. 2016 Mar;62(3):409-13. doi: 10.1097/MPG.0000000000000964.

PMID:
26308312
3.

A retrospective review of cyproheptadine for feeding intolerance in children less than three years of age: effects and side effects.

Merhar SL, Pentiuk SP, Mukkada VA, Meinzen-Derr J, Kaul A, Butler DR.

Acta Paediatr. 2016 Aug;105(8):967-70. doi: 10.1111/apa.13477. Epub 2016 Jun 10.

PMID:
27194450
4.

Cyproheptadine for the treatment of functional abdominal pain in childhood: a double-blinded randomized placebo-controlled trial.

Sadeghian M, Farahmand F, Fallahi GH, Abbasi A.

Minerva Pediatr. 2008 Dec;60(6):1367-74.

PMID:
18971897
5.

Effective prophylactic therapy for cyclic vomiting syndrome in children using amitriptyline or cyproheptadine.

Andersen JM, Sugerman KS, Lockhart JR, Weinberg WA.

Pediatrics. 1997 Dec;100(6):977-81.

PMID:
9374568
6.

Abdominal migraine: prophylactic treatment and follow-up.

Worawattanakul M, Rhoads JM, Lichtman SN, Ulshen MH.

J Pediatr Gastroenterol Nutr. 1999 Jan;28(1):37-40.

PMID:
9890466
7.

Cyproheptadine treatment in neuroleptic-induced akathisia.

Weiss D, Aizenberg D, Hermesh H, Zemishlany Z, Munitz H, Radwan M, Weizman A.

Br J Psychiatry. 1995 Oct;167(4):483-6.

PMID:
8829717
8.

Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.

Akhondzadeh S, Erfani S, Mohammadi MR, Tehrani-Doost M, Amini H, Gudarzi SS, Yasamy MT.

J Clin Pharm Ther. 2004 Apr;29(2):145-50.

PMID:
15068403
9.

Gastric electrical stimulation: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(16):1-79. Epub 2006 Aug 1.

10.

Effect of the 5-HT3 receptor antagonist, ondansetron, on gastric size in dyspeptic patients with impaired gastric accommodation.

Marzio L, Cappello G, Grossi L, Manzoli L.

Dig Liver Dis. 2008 Mar;40(3):188-93. doi: 10.1016/j.dld.2007.11.013. Epub 2008 Jan 31.

PMID:
18242155
11.

Functional dyspepsia symptoms, gastric emptying and satiety provocative test: analysis of relationships.

Cuomo R, Sarnelli G, Grasso R, Bruzzese D, Pumpo R, Salomone M, Nicolai E, Tack J, Budillon G.

Scand J Gastroenterol. 2001 Oct;36(10):1030-6.

PMID:
11589374
12.

Case study: cyproheptadine and aggression in a five-year-old boy.

Strayhorn JM Jr.

J Am Acad Child Adolesc Psychiatry. 1998 Jun;37(6):668-70.

PMID:
9628088
13.

Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis.

Mansi C, Borro P, Giacomini M, Biagini R, Mele MR, Pandolfo N, Savarino V.

Aliment Pharmacol Ther. 2000 May;14(5):561-9.

14.

Impact of delayed gastric emptying on the outcome of antireflux surgery.

Bais JE, Samsom M, Boudesteijn EA, van Rijk PP, Akkermans LM, Gooszen HG.

Ann Surg. 2001 Aug;234(2):139-46.

15.

Use of cyproheptadine in young children with feeding difficulties and poor growth in a pediatric feeding program.

Sant'Anna AM, Hammes PS, Porporino M, Martel C, Zygmuntowicz C, Ramsay M.

J Pediatr Gastroenterol Nutr. 2014 Nov;59(5):674-8. doi: 10.1097/MPG.0000000000000467.

PMID:
24941960
16.

Serotonin syndrome: early management with cyproheptadine.

McDaniel WW.

Ann Pharmacother. 2001 Jul-Aug;35(7-8):870-3.

PMID:
11485136
17.

Gastrointestinal motility and sensory abnormalities may contribute to food refusal in medically fragile toddlers.

Zangen T, Ciarla C, Zangen S, Di Lorenzo C, Flores AF, Cocjin J, Reddy SN, Rowhani A, Schwankovsky L, Hyman PE.

J Pediatr Gastroenterol Nutr. 2003 Sep;37(3):287-93.

PMID:
12960651
18.

Dyspeptic symptoms in children: the result of a constipation-induced cologastric brake?

Boccia G, Buonavolontà R, Coccorullo P, Manguso F, Fuiano L, Staiano A.

Clin Gastroenterol Hepatol. 2008 May;6(5):556-60. doi: 10.1016/j.cgh.2008.01.001. Epub 2008 Apr 18.

PMID:
18378497
19.

Reversal of gastric electrical dysrhythmias by cisapride in children with functional dyspepsia. Report of three cases.

Cucchiara S, Minella R, Riezzo G, Vallone G, Vallone P, Castellone F, Auricchio S.

Dig Dis Sci. 1992 Jul;37(7):1136-40.

PMID:
1618063
20.

Endoscopic intrapyloric injection of botulinum toxin A in the treatment of children with gastroparesis: a retrospective, open-label study.

Rodriguez L, Rosen R, Manfredi M, Nurko S.

Gastrointest Endosc. 2012 Feb;75(2):302-9. doi: 10.1016/j.gie.2011.09.042.

Supplemental Content

Support Center